United States Office of National Drug Control Policy

Download PDF

Recent Publications on United States Office of National Drug Control Policy:
Hypertension control at physicians' offices in the United States. BACKGROUND: Uncontrolled hypertension is a common and important risk...	25th April, 2008	Division for Heart Disease and Stroke Prevention, National Center for	Am J Hypertens. 2008 Feb;21(2):136-42. Epub 2008 Jan 10. DOI Direct Link
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006. Generally, live-virus vaccines are contraindicated for pregnant women...	15th April, 2008	Division of Epidemiology, Office of Biostatistics and Epidemiology, Center	Vaccine. 2008 May 2;26(19):2428-32. Epub 2008 Mar 17. DOI Direct Link
Improving physician and medical student education in substance use disorders. Medical and psychosocial problems related to substance use disorders...	2nd November, 2007	Dual Diagnosis Program, Middlesex Hospital, 28 Crescent St, Middletown, CT	J Am Osteopath Assoc. 2007 Sep;107(9 Suppl 5):ES27-38.
Science in the regulatory setting: a challenging but incompatible mix? Regulatory decisions informed by sound science have an important role in...	24th October, 2007	Office of Dietary Supplements, National Institutes of Health, 6100	Novartis Found Symp. 2007;282:59-68; discussion 69-76, 212-8.
Price and purity analysis for illicit drug: data and conceptual issues. Data on illicit drug purity and prices are invaluable but challenging....	16th October, 2007	Carnegie Mellon University, Qatar Campus and Heinz School of Public	Drug Alcohol Depend. 2007 Sep;90 Suppl 1:S61-8. Epub 2006 Sep 12. DOI Direct Link
→View more research publications.

BioNews Results for United States Office of National Drug Control Policy:
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patien	Pharma Live:  Jul 1 2008 9:24AM Matching: united states office national drug control policy
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patien	DiGiTAL50:  Jul 1 2008 5:47PM Matching: united states office national drug control policy
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patien	San Antonio Business Journal:  Jun 30 2008 12:40PM Matching: united states office national drug control policy
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patien	Nashville Business Journal:  Jun 30 2008 12:36PM Matching: united states office national drug control policy
Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patien	Columbus Business First:  Jun 30 2008 12:35PM Matching: united states office national drug control policy
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

BioPortfolio Ltd. offers e-mail and postal lists for United States Office of National Drug Control Policy scientists - we have details of around 2 individuals working on United States Office of National Drug Control Policy .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.